Kim Tae-han

President and CEO
Samsung BioLogics

Tae Han Kim is President and CEO of Samsung BioLogics. He was previously in charge of strategic business development, as EVP of Samsung Electronics until 2011.

During this role and responsibility, he established a Joint Venture with Quintiles, and another JV with Biogen-Idec for biologics business.

He began his career with Samsung in 1979. He led the business and financial restructuring of Samsung General Chemicals for 1998-2003, and played a key role in establishing a JV with Total, a French Petrochemical company. He played a senior leadership for successful integration of the JV with Total, and executed multiple plant expansion projects for 2004-2007.

He received his Ph D in chemical engineering from the University of Texas at Austin in 1988 under the sponsorship of Samsung.

2011 to
President and CEO, Samsung BioLogics
2008 - 2011 EVP, Strategic Business Development, Samsung Electronics
2007 - 2008 Senior VP, Corporate Strategy, Samsung Group Headquarters
2003 - 2007 Senior VP, Samsung Total Joint Venture
1995 - 2003 VP and General Manager, Samsung General Chemicals
1992 - 1995 General Manager, Strategic Planning
Chairman’s Office of Samsung Group
1979 - 1992 Research and Process Engineer, Samsung Central R&D and manufacturing plants
Education and Training:
2006 CEO Course of Wharton Business School
1983 - 1988 MS and PhD in Chemical Engineering, University of Texas at Austin
1975 - 1979 BS in Polymer Science, Kyungbook National University
Professional Society:

Chairman, Korea Biomedicine Industry Association
Senior Member, National Academy of Engineering of Korea
Member, Korean Society of Biotechnology and Bioengineering


He has been married for 27 years, and has two daughters

  • Corporate Sponsors


  • 日本経済新聞電子版
  • NIKKEI asian review
  • 日経中文網
  • #

Secretariat of 18th Nikkei Global Management Forum (NGMF2016)